kg
man
schedul
revis
total
hip
prosthesi
otherwis
good
health
start
hemoglobin
hb
hematocrit
hct
gdl
respect
predon
unit
blood
state
wish
blood
use
surgeri
oxygen
transport
circulatori
system
describ
compensatori
mechan
take
place
respons
blood
loss
minimum
accept
hemoglobin
concentr
transfus
trigger
list
potenti
sourc
autolog
blood
explain
acut
isovolem
hemodilut
aihd
outlin
physiolog
respons
aihd
aihd
accomplish
patient
suitabl
candid
aihd
intraop
cell
salvag
modern
cell
salvag
devic
work
outlin
characterist
blood
obtain
cell
salvag
describ
indic
use
intraop
cell
salvag
explain
controversi
contraind
involv
intraop
cell
salvag
preoper
autolog
blood
donat
pabd
elig
contraind
pabd
outlin
disadvantag
risk
pabd
describ
postop
blood
salvag
explain
advantag
disadvantag
differ
autolog
blood
sourc
one
circul
major
function
carri
oxygen
tissu
use
metabol
oxygen
deliveri
oxygen
transport
product
two
factor
blood
flow
cardiac
output
co
amount
oxygen
carri
blood
arteri
oxygen
content
cao
co
cao
oxygen
content
blood
decreas
oxygen
deliveri
maintain
proportion
increas
co
oxygen
present
blood
two
form
bound
hb
dissolv
plasma
oxygen
content
ml
blood
describ
equat
cao
hb
sao
pao
cao
arteri
oxygen
content
millilit
oxygen
per
ml
blood
sao
percent
hb
satur
oxygen
pao
partial
pressur
arteri
oxygen
normal
condit
eg
absenc
pulmonari
diseas
normal
hb
physiolog
shunt
oxyhemoglobin
satur
approxim
partial
pressur
dissolv
oxygen
approxim
mmhg
cao
calcul
follow
cao
gdl
mmhg
ml
ml
blood
calcul
demonstr
amount
oxygen
dissolv
plasma
ml
blood
neglig
compar
amount
carri
hb
ml
blood
furthermor
oxyhemoglobin
bind
factor
sao
constant
normal
condit
seen
cao
vari
almost
linearli
hb
concentr
abnorm
condit
obes
term
pregnanc
rapid
fall
sao
induct
anesthesia
result
immedi
decreas
cao
consequ
tachycardia
may
may
suffici
maintain
normal
blood
loss
occur
surgeri
loss
intravascular
volum
reduct
oxygencarri
capac
loss
hb
intravascular
volum
decreas
compensatori
vasoconstrict
tachycardia
occur
attempt
preserv
co
continu
volum
loss
result
decreas
co
caus
reduct
oxygen
deliveri
tissu
restor
intravascular
volum
infus
either
colloid
solut
ratio
blood
loss
crystalloid
solut
ratio
allow
normal
co
mainten
hemodynam
stabil
sever
mechan
avail
respond
loss
oxygencarri
capac
first
restor
intravascular
volum
co
may
actual
increas
maintain
even
increas
oxygen
deliveri
second
tissu
level
oxygen
extract
may
increas
normal
mix
venou
oxygen
satur
approxim
indic
avail
oxygen
extract
therefor
substanti
reserv
oxygen
avail
tissu
use
simpli
increas
amount
extract
blood
loss
continu
surgeri
even
intravascular
volum
maintain
oxygencarri
capac
eventu
fall
low
meet
metabol
demand
red
cell
transfus
requir
minimum
safe
level
hb
transfus
trigger
question
much
attent
focus
awar
acquir
immunodefici
syndrom
aid
transfusionrel
diseas
led
desir
withhold
blood
transfus
absolut
necessari
anim
model
experi
otherwis
healthi
jehovah
wit
known
surviv
possibl
hct
hb
gdl
normovolemia
maintain
experi
chronic
anem
patient
renal
failur
patient
shown
hct
low
routin
toler
data
appar
previous
recommend
transfus
trigger
hb
gdl
hct
unnecessarili
restrict
theoret
model
develop
determin
critic
hct
oxygen
deliveri
inadequ
meet
metabol
need
condit
normal
system
oxygen
consumpt
otherwis
healthi
patient
critic
hct
hb
gdl
increas
system
oxygen
consumpt
factor
typic
postsurg
patient
increas
critic
hct
base
data
well
clinic
studi
current
us
nation
institut
health
recommend
trigger
transfus
hb
gdl
hct
approxim
mani
clinician
accept
hct
low
otherwis
healthi
patient
transfus
trigger
may
differ
patient
cardiac
diseas
maxim
stress
oxygen
deliveri
occur
heart
avail
oxygen
normal
extract
oppos
bodi
whole
cao
drop
reserv
increas
extract
low
avail
compensatori
mechan
increas
coronari
blood
flow
patient
coronari
arteri
diseas
abil
increas
coronari
blood
flow
may
compromis
critic
hct
level
may
much
higher
therefor
patient
coronari
arteri
diseas
probabl
receiv
blood
maintain
hct
approxim
similarli
patient
signific
valvular
heart
diseas
poor
ventricular
function
well
cao
limit
pulmonari
diseas
hypermetabol
state
larg
oxygen
extract
high
transfus
trigger
summari
although
may
possibl
determin
certainti
minimum
safe
hb
level
given
patient
guidelin
base
transfus
therapi
healthi
patient
seem
toler
hct
low
patient
cardiopulmonari
diseas
may
requir
hct
criteria
overal
medic
condit
likelihood
continu
blood
loss
may
use
modifi
transfus
trigger
transfus
red
blood
cell
undertaken
increas
oxygencarri
capac
never
volum
expans
alon
medic
procedur
benefit
transfus
alway
weigh
risk
physician
awar
danger
associ
homolog
blood
transfus
well
increas
pressur
public
avoid
transfus
properli
led
increas
use
autolog
blood
sourc
sourc
preoper
autolog
blood
donat
acut
isovolem
hemodilut
aihd
intraop
cell
salvag
postop
cell
salvag
role
play
avoid
homolog
transfus
aihd
procedur
whole
blood
remov
periop
period
intravascular
volum
maintain
normal
level
simultan
infus
crystalloid
colloid
solut
blood
withdrawn
standard
blood
bag
contain
anticoagul
avail
transfus
patient
either
oper
postop
period
way
autolog
whole
blood
contain
red
cell
clot
factor
platelet
avail
advantag
summar
tabl
understand
aihd
may
safe
accomplish
necessari
understand
physiolog
respons
use
previous
discuss
product
co
cao
isovolem
hemodilut
occur
red
cell
remov
circul
cao
blood
decreas
might
expect
would
therefor
decreas
surprisingli
hct
decreas
actual
increas
baselin
hemodilut
alter
rheolog
properti
blood
blood
viscos
decreas
hemodilut
effect
lower
system
vascular
resist
svr
increas
venou
return
result
increas
stroke
volum
co
increas
proport
cao
decreas
rise
furthermor
rise
co
accomplish
without
increas
heart
rate
intravascular
volum
maintain
hemodilut
hct
caus
increas
fall
control
valu
hct
approxim
reach
addit
isovolem
hemodilut
local
tissu
oxygen
preserv
even
enhanc
homogen
distribut
capillari
blood
flow
studi
tissu
electrod
shown
hypox
microarea
occur
isovolem
hemodilut
aihd
accomplish
earli
periop
period
usual
induct
anesthesia
blood
remov
patient
via
largebor
intraven
cathet
store
standard
blood
bag
contain
anticoagul
arteri
cathet
may
use
collect
autolog
blood
found
less
satisfactori
simultan
crystalloid
ratio
colloid
albumin
hydroxymethyl
starch
dextran
ratio
infus
anoth
largebor
intraven
cathet
amount
blood
remov
calcul
formula
use
calcul
allow
blood
loss
typic
use
follow
formula
hct
start
hematocrit
hct
b
target
hematocrit
hemodilut
ebv
estim
blood
volum
typic
target
hct
mid
upper
use
allow
substanti
hemodilut
yet
allow
margin
safeti
blood
loss
begin
occur
surgeri
instanc
hct
ebv
kg
mlkg
ml
choos
hct
b
formula
yield
ml
thu
unit
patient
blood
could
remov
later
retransfus
unit
blood
remov
remain
constant
may
increas
cao
fall
red
blood
cell
remov
co
increas
lower
svr
improv
venou
return
without
increas
heart
rate
benefici
redistribut
capillari
blood
flow
red
blood
cell
loss
reduc
millilit
surgic
hemorrhag
provid
fresh
whole
blood
transfus
requir
tissu
perfus
improv
viscos
diminish
label
number
consecut
blood
retransfus
revers
order
collect
first
unit
remov
least
dilut
richest
red
cell
plasma
factor
platelet
therefor
last
unit
retransfus
blood
remov
hemodilut
may
store
oper
room
room
temperatur
maximum
hour
autolog
blood
remain
surgeri
may
store
blood
bank
refriger
use
invas
hemodynam
monitor
arteri
cathet
central
venou
cathet
mandatori
isovolem
hemodilut
facilit
serial
hct
measur
provid
guid
fluid
replac
co
rise
aihd
without
increas
heart
rate
develop
intraop
tachycardia
may
indic
hypovolemia
need
retransfus
urinari
cathet
monitor
urin
output
gaug
intravascular
volum
may
help
also
replac
autolog
blood
time
volum
crystalloid
initi
diuresi
indic
contraind
aihd
list
tabl
essenti
criteria
anticip
blood
loss
greater
ml
start
hct
greater
routin
use
aihd
describ
wide
varieti
case
includ
major
urolog
surgeri
orthoped
gynecolog
surgeri
plastic
reconstruct
surgeri
neurosurgeri
brain
tumor
resect
cardiothorac
surgeri
reduct
homolog
blood
usag
report
vari
age
per
se
contraind
hemodilut
use
describ
elderli
pediatr
popul
major
compensatori
mechan
hemodilut
abil
increas
blood
flow
isovolem
hemodilut
contraind
whose
abil
increas
either
system
coronari
blood
flow
might
compromis
thu
aihd
contraind
patient
anemia
carotid
arteri
stenosi
coronari
arteri
diseas
left
ventricular
dysfunct
aortic
mitral
valv
stenosi
fluid
shift
involv
aihd
contraind
patient
renal
pulmonari
diseas
signific
preexist
myocardi
brain
diseas
repres
contraind
isovolem
hemodilut
myocardi
ischemia
cerebr
hypoxia
major
associ
complic
coagulopathi
eman
reduc
factor
level
may
exacerb
dilut
effect
intraop
cell
salvag
refer
procedur
blood
lost
surgeri
collect
made
avail
transfus
back
patient
modern
cellsav
devic
function
fourstep
process
collect
blood
suction
surgic
field
mix
suction
tube
anticoagul
contain
either
heparin
citrat
suction
pressur
use
cell
salvag
system
low
mmhg
avoid
hemolysi
collect
blood
blood
pass
filter
remov
debri
store
canist
suffici
volum
present
process
concentr
mixtur
blood
anticoagul
irrig
solut
collect
suction
pass
centrifug
bowl
heavier
red
cell
retain
lighter
element
spun
discard
modern
cell
salvag
devic
process
return
unit
blood
everi
minut
face
rapid
bleed
salvag
autolog
blood
differ
bank
blood
sourc
autolog
blood
mani
way
salvag
autolog
blood
basic
suspens
red
cell
salin
hct
salvag
blood
may
vari
depend
amount
blood
collect
field
typic
rang
process
salvag
blood
contain
essenti
clot
factor
platelet
larg
volum
salvag
blood
use
replac
surgic
blood
loss
dilut
thrombocytopenia
low
level
clot
factor
may
result
salvag
blood
exhibit
storag
lesion
present
bank
blood
tabl
level
salvag
blood
normal
exhibit
low
ph
elev
potassium
microaggreg
format
found
bank
blood
chromiumlabel
studi
shown
salvag
red
cell
normal
surviv
time
bodi
reinfus
furthermor
indic
red
cell
viabil
resist
osmot
stress
superior
salvag
blood
compar
bank
blood
intraop
cell
salvag
use
varieti
surgic
set
abil
reduc
homolog
blood
use
well
document
intraop
cell
salvag
indic
case
blood
loss
expect
exceed
ml
mani
though
jehovah
wit
accept
cell
salvag
may
use
case
obtain
homolog
blood
difficult
rare
blood
type
multipl
antibodi
case
ideal
suit
cell
salvag
surgic
bleed
confin
discret
area
blood
loss
occur
slowli
wide
area
difficult
collect
typic
loss
surgic
field
occur
process
approxim
shed
blood
return
patient
recoveri
may
higher
case
abdomin
aortic
aneurysm
resect
blood
loss
well
local
use
intraop
cell
salvag
great
impact
vascular
surgeri
orthoped
surgeri
cardiac
surgeri
also
commonli
use
urolog
trauma
transplant
neurosurg
procedur
averag
homolog
blood
requir
decreas
percentag
patient
requir
homolog
blood
product
sharpli
increas
one
studi
involv
vascular
surgeri
patient
anoth
studi
major
center
demonstr
total
institut
red
cell
requir
obtain
intraop
cell
salvag
involv
intraop
cell
salvag
major
controversi
regard
intraop
cell
salvag
involv
use
oncolog
surgeri
contamin
trauma
case
situat
question
aris
concern
possibl
intravascular
dissemin
unwant
materialin
one
case
tumor
cell
case
bacteriabi
use
cell
salvag
demonstr
oncolog
surgeri
tumor
cell
may
surviv
process
suspend
along
red
cell
transfus
back
patient
thu
expert
feel
intraop
cell
salvag
use
oncolog
surgeri
howev
demonstr
transfus
malign
cell
result
dissemin
tumor
mani
form
cancer
tumor
cell
may
recov
blood
despit
fact
bloodborn
spread
occur
particular
reason
wish
avoid
use
homolog
transfus
oncolog
surgeri
homolog
transfus
shown
produc
immunosuppress
effect
result
earlier
tumor
recurr
decreas
surviv
time
patient
form
cancer
intraop
cell
salvag
may
advantag
case
one
group
studi
look
outcom
cell
salvag
patient
undergo
major
urolog
oncolog
procedur
evid
bloodborn
dissemin
high
tumor
recurr
rate
found
patient
use
cell
salvag
case
recommend
possibl
compromis
use
cell
salvag
suction
dissect
tumorfre
area
employ
separ
suction
collect
discard
materi
actual
tumor
dissect
nonetheless
clinic
studi
necessari
fulli
resolv
issu
abdomin
trauma
shed
blood
frequent
contamin
intestin
content
red
cell
bind
bacteria
surviv
process
cell
salvag
equip
transfus
back
patient
whether
transfus
contamin
blood
contribut
morbid
question
mani
expert
feel
patient
expos
bacteri
load
natur
injuri
prophylact
antibiot
significantli
reduc
risk
sepsi
consequ
littl
addit
danger
bacteria
salvag
blood
patient
spare
danger
associ
homolog
blood
author
feel
salvag
contamin
blood
use
lifesav
measur
blood
avail
definit
answer
question
await
clinic
trial
cell
salvag
use
presenc
topic
hemostat
agent
povidoneiodin
polymyxin
bacitracin
topic
antibiot
use
irrig
solut
use
present
contraind
shed
blood
contamin
amniot
fluid
present
cell
salvag
technolog
requir
special
train
personnel
oper
equip
individu
free
activ
process
consequ
someon
anesthesiologist
care
patient
receiv
respons
pabd
refer
donat
patient
blood
oper
storag
possibl
transfus
intraop
postop
nation
multicent
studi
reveal
much
blood
transfus
elect
surgeri
could
obtain
pabd
clearli
drive
forc
behind
increas
interest
pabd
time
fear
transfus
transmiss
virus
particularli
human
immunodefici
viru
hiv
use
pabd
peak
provid
unit
blood
collect
unit
state
use
pabd
declin
recent
year
unit
collect
unit
red
blood
cell
transfus
provid
pabd
pabd
clearli
shown
reduc
patient
exposur
homolog
blood
pabd
limit
case
reason
likelihood
red
cell
transfus
requir
periop
period
surgic
blood
loss
ml
anticip
surgic
blood
schedul
serv
guid
whether
transfus
like
patient
encourag
donat
blood
procedur
littl
chanc
signific
blood
loss
criteria
donat
autolog
blood
less
stringent
volunt
donat
autolog
donor
need
predon
hb
gdl
higher
hct
higher
age
criterion
predon
use
elderli
pediatr
popul
patient
weigh
kg
ml
whole
blood
donat
visit
patient
weigh
less
kg
volum
blood
remov
proport
weight
use
formula
pabd
requir
suitabl
interv
decis
undertak
surgeri
actual
date
oper
storag
life
blood
day
consequ
point
donat
blood
week
preoper
unit
blood
may
bank
everi
day
depend
donor
hct
donat
usual
made
everi
day
unit
store
day
preoper
event
surgeri
postpon
blood
may
frozen
prevent
outdat
necessari
rare
case
collect
larg
number
autolog
unit
requir
blood
may
frozen
store
long
period
time
patient
start
oral
iron
therapi
decis
predon
blood
made
use
recombin
erythropoietin
increas
amount
blood
avail
predon
decreas
interv
donat
describ
may
benefici
patient
anem
requir
larg
number
autolog
unit
presurg
interv
short
erythropoietin
therapi
describ
expens
remain
experiment
write
volum
blood
donat
ml
donor
weight
kg
ml
kg
sever
contraind
pabd
bacteria
may
prolifer
blood
storag
bacteremia
absolut
contraind
predon
lack
intraven
access
may
also
prohibit
predon
patient
posit
hiv
hepat
b
surfac
antigen
hb
ag
may
predon
blood
unit
must
label
segreg
protect
patient
might
erron
receiv
unit
well
worker
handl
retransfus
blood
requir
special
order
patient
physician
aspect
transfus
medicin
patient
cardiac
diseas
repres
gray
area
term
risk
center
exclud
patient
unstabl
angina
aortic
stenosi
left
main
coronari
arteri
diseas
accept
donor
stabl
coronari
arteri
diseas
investig
advoc
monitor
blood
pressur
electrocardiograph
puls
oxygen
satur
simultan
fluid
administr
physician
supervis
highrisk
patient
make
autolog
donat
precis
delin
risk
patient
await
outcom
futur
studi
contrast
homolog
blood
donat
histori
malign
contraind
pabd
first
note
risk
associ
blood
transfusionsabo
incompat
due
clinicaladministr
error
bacteri
contaminationar
elimin
use
pabd
reason
gener
argu
criteria
transfus
unit
autolog
blood
ie
transfus
trigger
unit
homolog
origin
other
argu
risk
associ
autolog
blood
decreas
rel
homolog
blood
riskbenefit
ratio
alter
criteria
transfus
autolog
blood
liber
paradox
use
pabd
result
lower
hct
averag
discharg
patient
mani
patient
predon
blood
adequ
time
interv
surgeri
fulli
regener
amount
blood
donat
thu
essenti
hemodilut
time
surgeri
receiv
blood
transfus
low
intraop
blood
loss
discharg
hct
lower
predon
similarli
era
costeffect
analysi
use
pabd
challeng
certain
surgic
set
ie
total
joint
replac
use
pabd
decreas
approxim
likelihood
patient
requir
homolog
transfus
set
ie
hysterectomi
mani
fewer
patient
requir
transfus
higher
percentag
unit
collect
pabd
discard
factor
increas
costeffect
pabd
includ
appropri
case
select
case
high
likelihood
unit
transfus
provid
long
enough
time
interv
donat
surgeri
allow
regen
erythropoiesi
occur
use
erythropoietin
therapi
conjunct
pabd
make
logic
sens
investig
patient
standpoint
multipl
trip
hospit
blood
center
donat
blood
inconveni
repeat
needl
stick
uncomfort
vasovag
reaction
occur
patient
lose
conscious
convuls
one
studi
autolog
donat
led
advers
event
requir
hospit
rate
higher
report
normal
volunt
blood
replac
preoper
autolog
blood
donat
transfus
reaction
clericaladministr
error
sepsi
bacteri
contamin
congest
heart
failur
volum
overload
blood
collect
autolog
use
subject
test
homolog
blood
use
cross
gener
blood
pool
discard
felt
patient
donat
blood
autolog
use
truli
volunt
donor
current
postop
blood
salvag
system
simpl
inexpens
shown
highli
effect
decreas
patient
requir
homolog
blood
product
system
consist
contain
attach
drain
place
surgic
wound
blood
collect
manner
defibrinogen
clot
even
absenc
anticoagul
enough
blood
collect
contain
hung
blood
pass
filter
convent
blood
administr
set
though
return
blood
high
fibrindegrad
product
use
seem
safe
associ
develop
dissemin
intravascular
coagul
dic
recent
howev
machin
introduc
like
intraop
salvag
devic
wash
blood
return
patient
postop
blood
salvag
system
use
commonli
cardiac
major
orthoped
surgeri
much
controversi
littl
consensu
exist
literatur
best
way
util
autolog
blood
expert
advoc
one
method
other
anoth
clear
method
superior
clear
someth
offer
rel
strength
weak
method
depend
clinic
circumst
tabl
pabd
disadvantag
rel
expens
subject
patient
risk
homolog
transfus
administr
error
storag
lesion
requir
substanti
time
interv
harvest
blood
date
surgeri
blood
donat
close
date
surgeri
insuffici
time
resynthesi
red
cell
compens
amount
remov
patient
rel
anem
time
surgeri
tend
leav
hospit
lower
hct
compar
control
howev
blood
collect
suitabl
interv
surgeri
substant
erythropoiesi
occur
pabd
highli
effect
method
prevent
exposur
homolog
blood
survey
hospit
recent
found
pabd
commonli
practic
method
blood
conserv
use
wide
accept
patient
state
unit
state
california
discuss
pabd
mandatori
part
inform
consent
oper
blood
transfus
like
aihd
advantag
inexpens
pointofcar
intervent
obviat
need
weeksinadv
plan
elimin
risk
administr
error
associ
store
blood
number
clinic
studi
purport
show
compar
effici
less
cost
pabd
cell
salvag
howev
studi
well
mathemat
model
shown
amount
red
blood
cell
save
aihd
quit
small
usual
clinic
insignific
aihd
clinic
use
low
hct
larg
surgic
blood
loss
must
safe
toler
number
author
rais
concern
iatrogen
introduct
risk
patient
previous
unappreci
cardiac
diseas
moder
profound
hemodilut
concern
use
aihd
probabl
limit
benefit
older
patient
use
probabl
least
controversi
greatest
benefit
pediatr
young
adult
patient
low
likelihood
unappreci
cardiac
diseas
anem
surgeri
larg
anticip
blood
loss
intraop
cell
salvag
wide
use
highli
effect
method
reduc
patient
exposur
homolog
blood
case
involv
larg
amount
bleed
procedur
rapidli
provid
autolog
blood
return
use
critic
larg
ground
costeffect
breakeven
point
unit
blood
howev
initi
set
collect
suction
part
apparatu
set
remaind
costli
portion
machin
suffici
amount
blood
collect
unnecessari
cost
associ
cell
salvag
decreas
though
theoret
concern
use
cell
salvag
case
involv
possibl
contamin
blood
malign
cell
bacteria
clinic
studi
experi
shown
increas
either
metastat
tumor
spread
infect
rate
intraop
cell
salvag
essenti
part
blood
conserv
program
scientif
advanc
past
decad
greatli
decreas
likelihood
transmiss
viral
diseas
hiv
hepat
c
via
blood
transfus
nonetheless
avoid
blood
transfus
remain
signific
concern
part
public
identifi
one
import
factor
patient
decis
seek
medic
care
furthermor
potenti
impact
emerg
diseas
west
nile
viru
sever
acut
respiratori
syndrom
sar
spongiform
encephalopathi
safeti
blood
suppli
concern
public
medic
commun
spur
factor
popular
socal
bloodless
surgeri
program
design
reduc
minim
exposur
homolog
blood
increas
program
offer
approxim
center
unit
state
comprehens
program
decreas
homolog
blood
exposur
util
techniqu
discuss
chapter
addit
factor
attempt
decreas
blood
loss
includ
care
surgic
techniqu
mainten
normothermia
use
region
anesthesia
select
patient
use
hypotens
gener
anesthesia
combin
use
appropri
transfus
trigger
techniqu
contribut
minim
patient
exposur
homolog
blood
